Shareholders' Equity (Tables)

9 Months Ended

Sep. 30, 2014

Equity [Abstract]

Share-Based Activity

Other information pertaining to share-based activity during the three and nine months ended September 30, 2014 and 2013 was as follows (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2014		2013		2014		2013
Share-based compensation expense	$	2,424	$	2,104	$	7,388	$	6,070
Fair value of shares vested	123		1,242		10,481		11,743
Cash received from option exercises	504		9,561		2,150		23,289
Tax benefit from option exercises	198		680		2,288		1,890

Schedule Of Changes In Non-Vested Restricted Shares

A summary of the status of non-vested restricted shares at September 30, 2014 and changes during the nine months ended September 30, 2014 is as follows:

			Weighted
	Number		Average
	of Shares		Grant Price
Non-vested shares at December 31, 2013	743,869		$	26.54
Shares granted	272,780		43.12
Shares vested	(249,854	)	23.39
Shares forfeited	(12,380	)	38.94
Non-vested shares at September 30, 2014	754,415		$	33.38

Schedule Of Stock Option Activity

A summary of stock option activity for the nine months ended September 30, 2014 is summarized as follows:

					Weighted
			Weighted		Average
			Average		Remaining
	Number		Exercise		Contractual
	of Shares		Price		Term (in years)
Outstanding at December 31, 2013	270,464		$	23.16	2.5
Options exercised with total intrinsic value of $2.2 million	(89,481	)	24.03
Outstanding, Vested and Exercisable at September 30, 2014 with an aggregate intrinsic value of $4.9 million	180,983		$	22.73	1.8

Schedule Of Reconciliation Of Numerator And Denominators Of Basic And Diluted Earnings Per Share

The following is a reconciliation of the numerator and denominators of basic and diluted earnings (loss) per share (in thousands, except per share amounts):

	Three Months Ended September 30,							Nine Months Ended September 30,
	Earnings			Shares	Per Share			Earnings		Shares	Per Share
	(Numerator)			(Denominator)	Amount			(Numerator)		(Denominator)	Amount
2014:
Net earnings (loss) from continuing operations attributable to AmSurg Corp. common shareholders (basic)	$	(10,704	)	46,320	$	(0.23	)	$	25,569	36,620	$	0.70
Effect of dilutive securities options and non-vested shares	—			—				—		406
Net earnings (loss) from continuing operations attributable to AmSurg Corp. common shareholders (diluted)	$	(10,704	)	46,320	$	(0.23	)	$	25,569	37,026	$	0.69
2013:
Net earnings (loss) from continuing operations attributable to AmSurg Corp. common shareholders (basic)	$	16,659		31,376	$	0.53		$	52,192	31,267	$	1.67
Effect of dilutive securities options and non-vested shares	—			615				—		645
Net earnings (loss) from continuing operations attributable to AmSurg Corp. common shareholders (diluted)	$	16,659		31,991	$	0.52		$	52,192	31,912	$	1.64